BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 15284304)

  • 1. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
    Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
    Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients.
    Wang AY; Sea MM; Tang N; Sanderson JE; Lui SF; Li PK; Woo J
    J Am Soc Nephrol; 2004 Dec; 15(12):3134-43. PubMed ID: 15579517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
    Liao CT; Chen YM; Shiao CC; Hu FC; Huang JW; Kao TW; Chuang HF; Hung KY; Wu KD; Tsai TJ
    Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis.
    Pérez-Flores I; Coronel F; Cigarrán S; Herrero JA; Calvo N
    Adv Perit Dial; 2007; 23():140-3. PubMed ID: 17886621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.
    Bakkaloglu SA; Saygili A; Sever L; Noyan A; Akman S; Ekim M; Aksu N; Doganay B; Yildiz N; Duzova A; Soylu A; Alpay H; Sonmez F; Civilibal M; Erdem S; Kardelen F
    Nephrol Dial Transplant; 2009 Nov; 24(11):3525-32. PubMed ID: 19541662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Han SH; Lee SC; Ahn SV; Lee JE; Kim DK; Lee TH; Moon SJ; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
    Nephrol Dial Transplant; 2007 Sep; 22(9):2653-8. PubMed ID: 17517797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre.
    Chung SH; Heimbürger O; Lindholm B; Lee HB
    Nephrol Dial Transplant; 2005 Jun; 20(6):1207-13. PubMed ID: 15784640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
    Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients.
    Duman D; Tokay S; Toprak A; Duman D; Oktay A; Ozener IC; Unay O
    Nephrol Dial Transplant; 2005 May; 20(5):962-7. PubMed ID: 15741207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre.
    Fang W; Qian J; Lin A; Rowaie F; Ni Z; Yao Q; Bargman JM; Oreopoulos DG
    Nephrol Dial Transplant; 2008 Dec; 23(12):4021-8. PubMed ID: 18790809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers.
    Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
    Nephrol Dial Transplant; 2009 Dec; 24(12):3826-33. PubMed ID: 19574337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular water/intracellular water is a strong predictor of patient survival in incident peritoneal dialysis patients.
    Chen W; Guo LJ; Wang T
    Blood Purif; 2007; 25(3):260-6. PubMed ID: 17429200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention.
    Fathi RB; Gurm HS; Chew DP; Gupta R; Bhatt DL; Ellis SG
    Am Heart J; 2005 Dec; 150(6):1190-7. PubMed ID: 16338257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.